NewsRx

Search our medical news database

Rexahn Pharmaceuticals, Inc.

Rexahn Pharmaceuticals to Present at the Bio 2009 International Convention

Published in Cancer Weekly, May 26th, 2009

Rexahn Pharmaceuticals, Inc. (NYSE Amex:RNN), a clinical stage biopharmaceutical company developing first-in-class oncology and CNS therapeutics, announced that it will present at the BIO 2009 International Convention at the Georgia World Congress Center (Room 314, Building A, Level 3) in Atlanta, GA on Wednesday, May 20, 2009 at 3:00 PM ET.

Rexahn’s Senior Business Development Director, Wendy Tsai, and Chief Business Officer, Rick Soni, will provide a strategic business update of Rexahn’s recent clinical and financing milestones, opportunities for licensing and alliances, and an overview of its R&D pipeline.

Rexahn currently has three drug...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook